Search results for:
Haloperidol
haloperidol
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Haldol |
CONCENTRATE, ORAL |
2 mg/mL |
|
|
|
|
| Haldol |
SOLUTION, INJECTABLE |
5 mg/mL |
|
|
|
|
| Haldol Decanoate |
SOLUTION, INTRAMUSCULAR |
decanoate 50 mg/mL |
|
|
|
|
| Haldol |
TABLET, ORAL |
0.5 mg, 1 mg, 2 mg, 5 mg, 20 mg |
|
|
|
|
Last updated: Aug. 10, 2022
Non-ICU Setting: Discourage IV administration (Exception: Critical Care, Oncology, Neurology, Psychiatry, ICU, Palliative Care prescribers). If necessary, give IVPB in 100 ml D5W over 1 hour.
Haloperidol lactate may be given via subcutaneous injection (e.g. in Palliative Care patients).